Ocugen closes $130M of 6.75% convertible senior notes due 2034, net proceeds ~$112.6M

Ocugen, Inc.

Closed $130.0M aggregate principal of 6.75% Convertible Senior Notes due 2034, including full $15M over-allotment exercise.
Net proceeds ~$112.6M after discount and expenses; offering price was 90% of principal.
Used $32.7M to fully repay outstanding loan under Avenue Capital Group agreement plus prepayment fees.
Remaining net proceeds for general corporate purposes; cash runway extended into 2028.
CEO cites momentum to advance three late-stage programs targeting three BLA filings by 2028.

item 2.03item 1.01item 3.02item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.